Abstract
Low-vision rehabilitation (LVR) aims to improve the functioning of patients with chronic uncorrectable visual impairment. LVR is inherently a patient-centered intervention since its approach and goals are dictated by the needs and abilities of each individual patient. Accordingly, it is essential to have patient-centered outcome (PCO) measures to assess and compare the efficacy and effectiveness of low-vision interventions; however, there is a lack of evidence on the effectiveness of LVR interventions. We reviewed the literature in order to identify randomized controlled trials (RCTs) in the field of LVR and the outcome measures used to assess patient functioning in these trials. We identified 15 RCTs of LVR that employed nine unique patient-reported, five unique performance-based, and one hybrid (combined patient-reported and performance) outcome measures. Since these trials used distinct tools to assess patient functioning, it is difficult to compare the effectiveness of competing rehabilitation interventions across studies. Selecting valid outcome measures that are both relevant to LVR goals of specific patient populations and that measure functioning across a range of visually demanding tasks could improve the ability to detect the effect of LVR and to compare rehabilitation strategies. There are advantages and limitations to the use of both patient-reported and performance-based outcome measures, and additional work should be undertaken to explore the relationship between these modes of assessment, as well as strategies for optimally integrating these approaches. Careful selection of outcome measures in the design of future RCTs in LVR may lead to improved understanding of the effectiveness of LVR and, ultimately, to improved functioning of patients with low vision.
Similar content being viewed by others
References
US Department of Health and Human Services. Vision research—a national plan: 1999–2003. Bethesda: National Eye Institute. NIH Publication 98-4120.
Dandona L, Dandona R. Revision of visual impairment definitions in the International Statistical Classification of Diseases. BMC Med. 2006;4:7.
Congdon N, O’Colmain B, Klaver CCW, Klein R, Muñoz B, Friedman DS, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–85.
Binns AM, Bunce C, Dickinson C, Harper R, Tudor-Edwards R, Woodhouse M, et al. How effective is low vision service provision? A systematic review. Surv Ophthalmol. 2012;57:34–65.
Jampel HD. Patient-centered outcomes research: evolution, definition, and implications. Ophthalmology. 2013;120:655–6.
Healthy People 2020. http://www.healthypeople.gov/. Accessed 21 Dec 2015.
Stelmack JA, Tang XC, Reda DJ, Rinne S, Mancil RM, Massof RW, et al. Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT). Arch Ophthalmol. 2008;126:608–17.
Massof RW, Rubin GS. Visual function assessment questionnaires. Surv Ophthalmol. 2001;45:531–48.
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–8.
Massof RW. Understanding Rasch and Item Response Theory Models: applications to the estimation and validation of interval latent trait measures from responses to rating scale questionnaires. Ophthalmic Epidemiol. 2011;18:1–19.
Warrian KJ, Altangerel U, Spaeth GL. Performance-based measures of visual function. Surv Ophthalmol. 2010;55:146–61.
Richman J, Lorenzana LL, Lankaranian D, Dugar J, Mayer JR, Wizov SS, et al. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol. 2010;17:144–51.
Law M, Baptiste S, McColl M, Opzoomer A, Polatajko H, Pollock N. The Canadian occupational performance measure: an outcome measure for occupational therapy. Can J Occup Ther. 1990;57:82–7.
Kempen GI, Miedema I, Ormel J, Molenaar W. The assessment of disability with the Groningen Activity Restriction Scale. Conceptual framework and psychometric properties. Soc Sci Med. 1996;43:1601–10.
Sonn U, Asberg KH. Assessment of activities of daily living in the elderly. A study of a population of 76-year-olds in Gothenburg, Sweden. Scand J Rehabil Med. 1991;23:193–202.
Baum C, Edwards D. Activity card sort: test manual. St Louis: Washington University School of Medicine; 2001.
Stelmack JA, Stelmack TR, Massof RW. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci. 2002;43:2859–68.
Massof RW, Stelmack JA. Interpretation of low-vision rehabilitation outcome measures. Optom Vis Sci. 2013;90:788–98.
Massof RW. A systems model for low vision rehabilitation: II. Measurement of vision disabilities. Optom Vis Sci. 1998;75:349–73.
Becker SW, Lambert RW, Schulz EM, Wright BD, Burnet DL. An instrument to measure the activity level of the blind. Int J Rehabil Res. 1985;8:415–24.
Weih LM, Hassell JB, Keeffe J. Assessment of the impact of vision impairment. Invest Ophthalmol Vis Sci. 2002;43:927–35.
Wolffsohn JS, Cochrane AL. Design of the low vision quality-of-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation. Am J Ophthalmol. 2000;130:793–802.
Stelmack JA, Szlyk JP, Stelmack TR, Demers-Turco P, Williams RT, Moran D, et al. Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire. Invest Ophthalmol Vis Sci. 2004;45:3919–28.
Massof RW, Ahmadian L, Grover LL, Deremeik JT, Goldstein JE, Rainey C, et al. The Activity Inventory: an adaptive visual function questionnaire. Optom Vis Sci. 2007;84:763–74.
Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, et al. Improving function in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2013;120:1649–55.
Pearce E, Crossland MD, Rubin GS. The efficacy of low vision device training in a hospital-based low vision clinic. Br J Ophthalmol. 2011;95:105–8.
Dunbar HMP, Crossland MD, Bunce C, Egan C, Rubin GS. The effect of low vision rehabilitation in diabetic eye disease: a randomised controlled trial protocol. Ophthalmic Physiol Opt. 2012;32:282–93.
McCabe P, Nason F, Demers Turco P, Friedman D, Seddon JM. Evaluating the effectiveness of a vision rehabilitation intervention using an objective and subjective measure of functional performance. Ophthalmic Epidemiol. 2000;7:259–70.
Lamoureux EL, Pallant JF, Pesudovs K, Hassell JB, Keeffe JE. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis. Invest Opthalmol Vis Sci. 2006;47:4732.
Lamoureux EL, Pallant JF, Pesudovs K, Rees G, Hassell JB, Keeffe JE. The effectiveness of low-vision rehabilitation on participation in daily living and quality of life. Invest Ophthalmol Vis Sci. 2007;48:1476–82.
Christy B, Keeffe JE, Nirmalan PK, Rao GN. A randomized controlled trial assessing the effectiveness of strategies delivering low vision rehabilitation: design and baseline characteristics of study participants. Ophthalmic Epidemiol. 2010;17:203–10.
Finger RP, Tellis B, Crewe J, Keeffe JE, Ayton LN, Guymer RH. Developing the impact of Vision Impairment–Very Low Vision (IVI–VLV) questionnaire as part of the LoVADA protocol. Invest Ophthalmol Vis Sci. 2014;55:6150–8.
van Nispen RMA, Knol DL, Langelaan M, van Rens GHMB. Re-evaluating a vision-related quality of life questionnaire with item response theory (IRT) and differential item functioning (DIF) analyses. BMC Med Res Methodol. 2011;11:125.
van Nispen RMA, Knol DL, Neve HJ, van Rens GHMB. A multilevel item response theory model was investigated for longitudinal vision-related quality-of-life data. J Clin Epidemiol. 2010;63:321–30.
Burggraaff MC, van Nispen RMA, Knol DL, Ringens PJ, van Rens GHMB. Randomized controlled trial on the effects of CCTV training on quality of life, depression, and adaptation to vision loss. Invest Ophthalmol Vis Sci. 2012;53:3645–52.
Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item national eye institute visual function questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116:227–33.
Marella M, Pesudovs K, Keeffe JE, O’Connor PM, Rees G, Lamoureux EL. The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci. 2010;51:2878–84.
Brody BL, Roch-Levecq A-C, Gamst AC, Maclean K, Kaplan RM, Brown SI. Self-management of age-related macular degeneration and quality of life: a randomized controlled trial. Arch Ophthalmol. 2002;120:1477–83.
Scanlan JM, Cuddeford JE. Low vision rehabilitation: a comparison of traditional and extended teaching programs. J Vis Impair Blind. 2004;98:601–10.
Zijlstra GA, van Rens GH, Scherder EJ, Brouwer DM, van der Velde J, Verstraten PF, et al. Effects and feasibility of a standardised orientation and mobility training in using an identification cane for older adults with low vision: design of a randomised controlled trial. BMC Health Serv Res. 2009;9:153.
Smith HJ, Dickinson CM, Cacho I, Reeves BC, Harper RA. A randomized controlled trial to determine the effectiveness of prism spectacles for patients with age-related macular degeneration. Arch Ophthalmol. 2005;123:1042–50.
Szlyk JP, Stelmack J, Massof RW, Stelmack TR, Demers-Turco P, Williams RT, et al. Performance of the Veterans Affairs Low Vision Visual Functioning Questionnaire. J Vis Impair Blind. 2004;98:261–75.
Stelmack JA, Szlyk JP, Stelmack TR, Demers-Turco P, Williams RT, Moran D, et al. Measuring outcomes of vision rehabilitation with the Veterans Affairs Low Vision Visual Functioning Questionnaire. Invest Opthalmol Vis Sci. 2006;47:3253.
Stelmack JA, Tang XC, Reda DJ, Stroupe KT, Rinne S, Massof RW, et al. VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision. Ophthalmic Physiol Opt. 2012;32:461–71.
Legge GE, Ross JA, Luebker A, LaMay JM. Psychophysics of reading. VIII. The Minnesota Low-Vision Reading Test. Optom Vis Sci. 1989;66:843–53.
Baldasare J, Watson GR, Whittaker SG, Miller-Shaffer H. The development and evaluation of a reading test for low vision individuals with macular loss. J Vis Impair Blind. 1986;80(6):785–9.
Radner W, Obermayer W, Richter-Mueksch S, Willinger U, Velikay-Parel M, Eisenwort B. The validity and reliability of short German sentences for measuring reading speed. Graefes Arch Clin Exp Ophthalmol. 2002;240:461–7.
Ebert EM, Fine AM, Markowitz J, Maguire MG, Starr JS, Fine SL. Functional vision in patients with neovascular maculopathy and poor visual acuity. Arch Ophthalmol. 1986;104:1009–12.
Ramulu PY, Swenor BK, Jefferys JL, Rubin GS. Description and validation of a test to evaluate sustained silent reading. Invest Ophthalmol Vis Sci. 2013;54:673–80.
Rubin GS. Measuring reading performance. Vis Res. 2013;90:43–51.
Stelmack J, Stelmack TR, Fraim M, Warrington J. Clinical use of the Pepper Visual Skills for Reading Test in low vision rehabilitation. Am J Optom Physiol Opt. 1987;64:829–31.
Calabrèse A, Owsley C, McGwin G, Legge GE. Development of a Reading Accessibility Index using the MNREAD acuity chart. JAMA Ophthalmol. 2016;134:398–405.
Burggraaff MC, van Nispen RMA, Hoeben FP, Knol DL, van Rens GHMB. Randomized controlled trial on the effects of training in the use of closed-circuit television on reading performance. Invest Ophthalmol Vis Sci. 2012;53:2142–50.
Haymes SA, Johnston AW, Heyes AD. The development of the Melbourne low-vision ADL index: a measure of vision disability. Invest Ophthalmol Vis Sci. 2001;42:1215–25.
Haymes SA, Johnston AW, Heyes AD. Preliminary investigation of the responsiveness of the Melbourne Low Vision ADL index to low-vision rehabilitation. Optom Vis Sci. 2001;78:373–80.
Haymes SA, Johnston AW, Heyes AD. A weighted version of the Melbourne Low-Vision ADL index: a measure of disability impact. Optom Vis Sci. 2001;78:565–79.
Friedman SM, Munoz B, Rubin GS, West SK, Bandeen-Roche K, Fried LP. Characteristics of discrepancies between self-reported visual function and measured reading speed. Salisbury Eye Evaluation Project Team. Invest Ophthalmol Vis Sci. 1999;40:858–64.
Szlyk JP, Seiple W, Fishman GA, Alexander KR, Grover S, Mahler CL. Perceived and actual performance of daily tasks: relationship to visual function tests in individuals with retinitis pigmentosa. Ophthalmology. 2001;108:65–75.
Guralnik JM, Branch LG, Cummings SR, Curb JD. Physical performance measures in aging research. J Gerontol. 1989;44:M141–6.
Goldstein JE, Jackson ML, Fox SM, Deremeik JT, Massof RW, Low Vision Research Network Study Group. Clinically meaningful rehabilitation outcomes of low vision patients served by outpatient clinical centers. JAMA Ophthalmol. 2015;133:762–9.
West SK, Rubin GS, Munoz B, Abraham D, Fried LP. Assessing functional status: correlation between performance on tasks conducted in a clinic setting and performance on the same task conducted at home. The Salisbury Eye Evaluation Project Team. J Gerontol A Biol Sci Med Sci. 1997;52:M209–17.
Massof RW. A general theoretical framework for interpreting patient-reported outcomes estimated from ordinally scaled item responses. Stat Methods Med Res. 2014;23:409–29.
Rosen PN, Boer ER, Gracitelli CPB, Abe RY, Diniz-Filho A, Marvasti AH, et al. A portable platform for evaluation of visual performance in glaucoma patients. PLoS One. 2015;10:e0139426.
US Department of Health and Human Services, Food and Drug Administration. Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. http://www.fda.gov/downloads/Drugs/…/Guidances/UCM193282.pdf. Accessed 19 Apr 2016.
Noe G, Ferraro J, Lamoureux E, Rait J, Keeffe JE. Associations between glaucomatous visual field loss and participation in activities of daily living. Clin Exp Ophthalmol. 2003;31:482–6.
Brown JC, Goldstein JE, Chan TL, Massof R, Ramulu P, Low Vision Research Network Study Group. Characterizing functional complaints in patients seeking outpatient low-vision services in the United States. Ophthalmology. 2014;121(1655–1662):e1.
Turano KA, Geruschat DR, Stahl JW, Massof RW. Perceived visual ability for independent mobility in persons with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1999;40:865–77.
Jadad AR, Enkin MW. Bias in randomized controlled trials. In: Jadad A, Enkin M, editors. Randomized controlled trials: questions, answers and musings. 2nd ed. New York: Wiley; 2008. p. 29–47.
Jampel HD, Frick KD, Janz NK, Wren PA, Musch DC, Rimal R, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238–44.
Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS. Glaucoma and reading speed: the Salisbury Eye Evaluation project. Arch Ophthalmol. 2009;127:82–7.
McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol. 2007;7:30.
Atasavun Uysal S, Düger T. Visual perception training on social skills and activity performance in low-vision children. Scand J Occup Ther. 2012;19:33–41.
Ballemans J, Zijlstra GAR, van Rens GHMB, Schouten JSAG, Kempen GIJM. Usefulness and acceptability of a standardised orientation and mobility training for partially-sighted older adults using an identification cane. BMC Health Serv Res. 2012;12:141.
Eklund K, Sjöstrand J, Dahlin-Ivanoff S. A randomized controlled trial of a health-promotion programme and its effect on ADL dependence and self-reported health problems for the elderly visually impaired. Scand J Occup Ther. 2008;15:68–74.
Girdler SJ, Boldy DP, Dhaliwal SS, Crowley M, Packer TL. Vision self-management for older adults: a randomised controlled trial. Br J Ophthalmol. 2010;94:223–8.
Author Contributions
Each author meets the criteria for authorship laid out by the International Committee of Medical Journal Editors. Each author has given final approval for the manuscript to be submitted for consideration for publication. All authors agree to be accountable for all aspects of the work and Dr. Ehrlich will act as the overall guarantor. The individual contributions of each author are listed: Joshua Ehrlich: Conception and design of the study, writing of the manuscript. George Spaeth: Conception and design of the study, critical revision of the manuscript. Noelle Carlozzi: Critical revision of the manuscript. Paul Lee: Conception and design of the study, critical revision of the manuscript. This submission has not been previously published elsewhere and is not simultaneously being considered for any other publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Grants
This work was supported by the Heed Ophthalmic Foundation through an unrestricted Grant to Joshua Ehrlich (no Grant Number).
Conflict of interest
Joshua Ehrlich, George Spaeth, Noelle Carlozzi, and Paul Lee have no conflicts of interest that impacted or are likely to be perceived as impacting their contribution to this work. Paul Lee is a consultant to the Centers for Disease Control and Prevention. All money goes to his institution.
Rights and permissions
About this article
Cite this article
Ehrlich, J.R., Spaeth, G.L., Carlozzi, N.E. et al. Patient-Centered Outcome Measures to Assess Functioning in Randomized Controlled Trials of Low-Vision Rehabilitation: A Review. Patient 10, 39–49 (2017). https://doi.org/10.1007/s40271-016-0189-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40271-016-0189-5